← All trials
NCT03276910
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 8, 2017
- Primary completion
- Dec 22, 2017
- Completion date
- Jun 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Association Athletes For TransparencyLead sponsor
- University of LyonOverall official - principal investigator
- University of LyonCollaborator
- Ecole Nationale de Ski et d'AlpinismeCollaborator
- Partnership for Clean CompetitionCollaborator
- University of MilanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.